The path that PLUTO Inc. has taken

2024~

Introduction of technical Know-how related to atopy and the development of new drugs

2023

Development of a new GLP-1 drug

Introduction of technical Know-how for the treatment of sarcopenia and the development of new drugs

Signing a sales contract for the AniConju with Yuhan Corporation

Development of ‘AniConju’ PN injection for companion animals

2022

Establishment

Investment attraction from Pharma Research Co., Ltd.